Zdravlje has state-of-the-art, EU-GMP approved manufacturing facilities which serve approximately 40 countries from its base in Leskovac, Serbia. We have an uninterrupted supply track record over 70 years. Today our major markets include the EU, UK, Australia, North America, Latin America, Asia Pacific and Africa. We have capabilities across all major forms of oral solid (e.g. tablets, capsules) and non-sterile liquid (sprays, drops) production with a total annual capacity of approximately 1.7 billion units. We harness advanced manufacturing processes to manufacture products in immediate release (IR) and modified release (MR) forms. Products are manufactured, packaged, stored and released according to the highest European standards.
Finished products fully tested and released in the EU.
Tablets
Capsules
Liquids
1,7 billion
40 countries
EU, UK
North America
Asia Pacific, Middle East, Africa
Modified Release
Controlled Substances
Imprinting
EU Test & Release
Wet granulation:
Dry granulation:
Coating:
Annual Capacity: 1,3 billion tablets
Annual Capacity: 400 million capsules
Annual Capacity: 12 million bottles
Reach out to us and let’s discuss how we can support your pharmaceutical manufacturing needs.
Zdravlje Company Data | Terms Of Use | Privacy policy | Personal Data Processing
© 2025 Zdravlje AD Leskovac. All rights reserved.